ConcertAI: ASCO 2024 study demonstrates that AI-based clinical trial screening is more than 3x faster than traditional methods ...Middle East

PR Newswire - Economy
CAMBRIDGE, Mass., May 29, 2024 /PRNewswire/ -- ConcertAI, the leader in oncology predictive and generative AI SaaS and Real-World Data (RWD) Solutions for clinical research, announced the results of the study being presented at ASCO 2024 showing that its Digital Trial Solutions (DTS)...

Hence then, the article about concertai asco 2024 study demonstrates that ai based clinical trial screening is more than 3x faster than traditional methods was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( ConcertAI: ASCO 2024 study demonstrates that AI-based clinical trial screening is more than 3x faster than traditional methods )

Apple Storegoogle play

Last updated :

Also on site :



Latest News